At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 38 enrolled
Drug / intervention
Metronidazole +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Study to Evaluate the Relative Bioavailability of Two Metronidazole Vaginal Gel Formulations
In Brief
A Phase 1 clinical trial evaluating Metronidazole for Healthy. Completed, enrolled 38 participants across 1 site.
Detailed Summary
The primary object of this study was to evaluate the relative bioavailability of the test formulation of metronidazole vaginal gel with the already marketed reference formulation MetroGel-Vaginal Gel® in healthy adult female subjects.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesUnited States
Collaborators--
Timeline
Phase 1CompletedFinished
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartNov 2001
Primary CompletionNov 2001
Study CompletionJan 2002
First PostedNov 2009
TodayJul 2026
First PostedNov 26, 2009
Enrollment StartNov 1, 2001
Primary CompletionNov 1, 2001
Study CompletionJan 1, 2002
TodayJul 2, 2026
Enrollment to primary: 0 daysPosted 16.6 years ago
Interventions
Metronidazoledrug
Vaginal Gel, 0.75%
Metronidazoledrug
Vaginal Gel, 0.75%